Skip navigation

no spam, unsubscribe anytime.
Skip navigation
Goal: 30,000 Progress: 8,144
Sponsored by: The Breast Cancer Site

Today, the vast majority of medical research is done on men, with women compromising only one-third of test subjects.

The cause and rationale behind this is a long and complex one. In 1977, the FDA recommended that women of childbearing age essentially be excluded from clinical trials after medical disasters like the Thalidomide tragedy and synthetic estrogen known as DES, which led to malignancies in reproductive organs. Women's bodies also go through considerably more change then men's in the forms of menstruation, pregnancy, and menopause which can complicate research data sets.

But for those women who are willing to participate in medical research studies, all of the above facts are reasons why men and women must be separated when it comes to medical research.

Symptoms of medical complications, such as heart attacks, are experienced differently in men and women. A general unfamiliarity of women's symptoms when they don't match men's has cost countless lives in the form of misdiagnosis. Women also absorb and react to medicine differently than men which can lead to complications and side-effects unanticipated by male-dominated drug trials.

Clearly, something needs to be done. Women's health needs cannot be ignored any longer. While there is wisdom in the decision to limit women's participation in studies to protect the unborn, those women who do choose to participate in studies should not have their results scrutinized under the same standards as men. Quite simply, male and female bodies are different, and medical data should treat them as such.

Ask the FDA Center for Drug Evaluation and Research to require studies to separate their results by male and female for the entire research process rather than lumping them together and to draw separate recommendations for the safe use of medicine for men and women.

Sign Here






To the Director of the FDA Center for Drug Evaluation and Research,

I am writing to you today to express my concern after discovering that the FDA does not require medical research and drug trials to separate their findings by the sex of their participants. To get better data on the way women respond to specific drugs and treatment, this must change.

As you are no doubt aware, women and men do not always display the same signs, symptoms, or reactions to treatment. Symptoms of medical complications, such as heart attacks, are experienced differently in men and women. A general unfamiliarity of women's symptoms when they don't match men's has cost countless lives in the form of misdiagnosis. Women also absorb and react to medicine differently than men which can lead to complications and side-effects unanticipated by male-dominated drug trials.

I understand that in 1977, the FDA recommended that women of childbearing age essentially be excluded from clinical trials after medical disasters like the Thalidomide tragedy and synthetic estrogen known as DES, which led to malignancies in reproductive organs. I also realize that women's bodies also go through considerably more change then men's in the forms of menstruation, pregnancy, and menopause which can complicate research data sets.

While there is wisdom in the decision to limit women's participation in studies to protect the unborn, those women who do choose to participate in studies should not have their results scrutinized under the same standards as men. Quite simply, male and female bodies are different, and medical data should treat them as such.

Women need to benefit from medical trials by having researchers separate their data by sex. Please, change your policies to require studies to separate their results by male and female for the entire research process rather than lumping them together and to draw separate recommendations for the safe use of medicine for men and women.

Thank you,

Petition Signatures


Jun 23, 2018 Leora Yaffi
Jun 23, 2018 Candy Punia
Jun 23, 2018 Anne Reavis
Jun 23, 2018 Brittany Ford
Jun 23, 2018 (Name not displayed)
Jun 22, 2018 Jeffery Clifford
Jun 22, 2018 Diane Kalil
Jun 22, 2018 Barry Derr
Jun 22, 2018 Olga Maria de Almada
Jun 22, 2018 Terri Neizmik
Jun 22, 2018 Marilynn Baldwin
Jun 22, 2018 Konstantina Balaska
Jun 21, 2018 Val Laurent
Jun 21, 2018 Carolyn Black
Jun 21, 2018 Doria Whitlatch
Jun 21, 2018 joanne bramson
Jun 21, 2018 Keith Mearns
Jun 21, 2018 Bonnie Farmer
Jun 21, 2018 Renee Reyes
Jun 21, 2018 (Name not displayed)
Jun 21, 2018 Julie Hall
Jun 21, 2018 Elaine Lyons
Jun 20, 2018 J-F Briard
Jun 20, 2018 Maria Zambrano
Jun 20, 2018 kathy Fujimoto
Jun 20, 2018 jim bier An important reform is needed.
Jun 20, 2018 Lois Baum
Jun 20, 2018 Jessica Pollard
Jun 20, 2018 Victoria Rogerson
Jun 20, 2018 Debbie Eldridge
Jun 20, 2018 Heather Thompson
Jun 20, 2018 Rebecca Tresnak
Jun 20, 2018 Andrea Bradford
Jun 20, 2018 Adrianne Kendrick
Jun 20, 2018 Leigh Oaks
Jun 20, 2018 Eleni Bountalis
Jun 20, 2018 Amy Biggs
Jun 20, 2018 Natalie Bieniarz
Jun 20, 2018 Sabrina Lester-Granger
Jun 20, 2018 (Name not displayed)
Jun 20, 2018 Margaret Wing
Jun 20, 2018 (Name not displayed)
Jun 20, 2018 Tina Keeble
Jun 20, 2018 Abby Bernhardt
Jun 20, 2018 Deirdre Gately
Jun 19, 2018 jacqueline osuna
Jun 19, 2018 Sandra Vohs
Jun 19, 2018 Pamela DelPadre-Mahon
Jun 19, 2018 susan shi
Jun 19, 2018 Cyndi Fritzler

back to top

Pink Ribbon Womens Casual Shorts
Share this page and help fund mammograms: